Does EPA Lower CV Risk? REDUCE-IT Revisited
Deepak Bhatt, MD, MPH, discusses results from a trial suggesting that icosapent ethyl lowers the risk for ischemic events among patients with high triglycerides despite statin use.
Deepak Bhatt, MD, MPH, discusses results from a trial suggesting that icosapent ethyl lowers the risk for ischemic events among patients with high triglycerides despite statin use.
